论文部分内容阅读
小儿白血病占小儿各类恶性肿瘤的首位 ,由于强化化疗加髓外白血病的防治逐步完善 ,使 5年生存率明显提高 ,但中枢神经系统白血病 (ＣＮＳＬ)仍然是制约小儿急性白血病疗效的重要障碍 ,而且又是复发的一个重要因素。我们对近 5年来收治的小儿急性白血病合并ＣＮＳＬ的病例追踪随
Pediatric leukemia accounts for the first place of all kinds of malignant tumors in children. Due to the gradual improvement of the prevention and treatment of intensive chemotherapy and extramedullary leukemia, the 5-year survival rate has been significantly improved. However, central nervous system leukemia (CNSL) remains an important obstacle to the curative effect of pediatric acute leukemia. But also an important factor in relapse. We follow the case of pediatric acute leukemia with CNSL admitted in the past 5 years